Invention Grant
- Patent Title: P2X3, receptor antagonists for treatment of pain
-
Application No.: US13125935Application Date: 2009-10-21
-
Publication No.: US08598209B2Publication Date: 2013-12-03
- Inventor: Christopher S. Burgey , Zhengwu J. Deng , Diem N. Nguyen , Daniel V. Paone , Anthony W. Shaw , Anthony Ginnetti
- Applicant: Christopher S. Burgey , Zhengwu J. Deng , Diem N. Nguyen , Daniel V. Paone , Anthony W. Shaw , Anthony Ginnetti
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Sylvia A. Ayler; Gerard M. Devlin
- International Application: PCT/US2009/061409 WO 20091021
- International Announcement: WO2010/051188 WO 20100506
- Main IPC: A61K31/4412
- IPC: A61K31/4412 ; C07D213/24 ; C07D213/60
Abstract:
The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor subunit modulator.
Public/Granted literature
- US20110206783A1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN Public/Granted day:2011-08-25
Information query
IPC分类:
